![Prashant Kohli](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 48 480 $ in data 30/06/2026
Prashant Kohli currently works at Grace Therapeutics, Inc., as Chief Executive Officer & Director from 2023.
Mr. Kohli also formerly worked at Grace Therapeutics LLC, as Vice President-Commercial Operations from 2017 to 2021.
Mr. Kohli received his undergraduate degree from Augustana College (Illinois) and Masters Business Admin degree from The Wharton School of the University of Pennsylvania.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 18/07/2025 | 21.357 ( 0,13% ) | 48 480 $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| GRACE THERAPEUTICS, INC. | Amministratore Delegato | 04/04/2023 |
| Società | Posizione | Fine |
|---|---|---|
Grace Therapeutics LLC
 Grace Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Designs and develops drug delivery technology and products | Corporate Officer/Principal | 01/08/2021 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 4 |
|---|---|
Grace Therapeutics, Inc.
 Grace Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for rare and orphan diseases | Health Technology |
Augustana College (Illinois)
 Augustana College (Illinois) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Grace Therapeutics LLC
Grace Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Designs and develops drug delivery technology and products | Commercial Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
